RSS

vaccine

Biotechnology company, Bavarian Nordic, has revealed positive data from the extension study of its Phase II study investigating its universal respiratory syncytial virus (RSV) vaccine, MVA-BN RSV, in older adults. more

News

A new prophylactic vaccine aimed at providing immunity against several types of HIV-1 infection has provided promising results in a Phase I/IIa clinical trial, recently published in The Lancet, of just under 400 patients. more

News

Economic and health benefits should be taken into account when the government assess the value of vaccination, according to new research by the International Longevity Centre — UK (ILC-UK). more

News

A European research, development and innovation organisation, VTT Technical Research Centre of Finland, has developed a vaccine for piglets to reduce the use of antibiotics and help with the global issue of antimicrobial resistance (AMR). more

News

Dulas, British renewable energy specialist and manufacturer of solar-powered refrigerators, has delivered 50 vaccine refrigerators to Pakistan, supporting key humanitarian initiatives across the country. more

Technology

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability. more

News

A partnership has been formed between Horizon Discovery Group and The Pirbright Institute to cover collaborative work on a research programme aimed at deploying cell engineering to increase vaccine yields for livestock. more

News

A partnership agreement has been signed by BIA Separations, a biochromatography development and manufacturing company, and Nuvonis Technologies, a biotech company, to support the production of vaccine and gene therapy. more

News

As we embark on a difficult flu season, I look at why infection rates vary so much year on year and the potential universal vaccine one company is progressing through the clinical development stages. more

Opinion

Administration of quadrivalent flu jabs should be on the agenda for the NHS as fourth flu strain, known as ‘Japanese flu’ is becoming most prevalent in Europe, according to data and analytics company, GlobalData. more

Opinion

After the successful completion of the Phase I trial, Araclon Biotech and TFS International have announced a continuation of their partnership to advance the trial of the Alzheimer’s disease (AD) vaccine ABvac40 into Phase II. more

News

Sanofi is requesting that health authorities update information on its dengue vaccine Dengvaxia, as a result of a new analysis of long-term clinical trial data, which found differences in vaccine performance based on prior dengue infection. more

News

Global healthcare company Sanofi has announced it is investing €170 million to expand its vaccine manufacturing site in Val de Reuil, France. more

News

Researchers at the Scripps Research Institute (TSRI)  in California have developed a vaccine that blocks the ‘high’ of heroin. more

Opinion

A recent study, published in Nature Communications, has described how a candidate synthetic vaccine for polio has been developed with a method grown in plants that use virus like particles (VLPs). more

News

A dissolvable adhesive patch has been developed to offer a ‘painless’ alternative to the flu vaccine, which is traditionally delivered by injection. more

Technology

Researchers from the University of Hertfordshire have developed a new concept that may lead to the discovery of universal anti-influenza drugs, according to findings recently published in the journal Virology. more

News

The World Health Organisation Regional Office for Africa (WHO/AFRO) has announced that Ghana, Kenya and Malawi will take part in the malaria vaccine pilot implementation programme starting in 2018. more

News

Prevtec Microbia has been the recipient of a CAD $2.5 million investment from some of the company shareholders to support the launch of its second vaccine in the EU. more

News

Priyabrata Pattnaik, director, Worldwide Vaccine Initiative, Merck talks about the need for downstream processing within vaccine production. more

News